This in-person and live-streamed seminar highlights the transformative potential of Next-Generation Sequencing (NGS), Olink Proteomics in achieving comprehensive multi-omic insights. By integrating proteomics with genomics and other omics data, NGS enables deeper, more accurate understanding of complex biological systems.
Attendees will discover how leveraging NGS technologies can uncover new biomarkers, improve disease understanding, and drive advancements in precision medicine, offering true multi-omic outcomes for research and other advanced applications.
* Not able to make either session? Register for either option and receive the recording afterwards.
Guest speakers include:
Dr Clarissa Yates, CEO and Founder of Ketim Therapeutics
Dr Benjamin Cooper, Technical Officer - Olink at AGRF.
Q & A Panel Discussion: Have all your questions answered…
Dr Clarissa Yates, CEO & Founder at Ketim Therapeutics
Precision Medicine for Mental Health | Explore HT
Dr Clarissa Yates will be sharing her experience with Olink Explore HT and the significant impact it has had on her research. In her presentation, she will discuss how the platform’s comprehensive biomarker library enabled the discovery of novel biomarkers for postpartum depression, revealing insights that were previously unattainable. This pilot study marks a crucial step toward revolutionising precision medicine in mental healthcare, utilising a biomarker-driven approach to better understand and address mental health conditions like postpartum depression. Her work demonstrates the transformative potential of Olink Explore HT in advancing mental health research and improving patient outcomes.
Dr Benjamin Cooper, Technical Officer - Olink at AGRF
Exploring the Olink Platforms – Reveal, Target, and Explore HT
Dr Benjamin Cooper will focus on Olink's complete portfolio, including Olink® Reveal, Target and Explore HT. These workflows provide comprehensive proteomics solutions designed to accelerate research in a wide array of applications. He will emphasise how Olink’s advanced technologies come together to form a powerful, integrated proteomics platform that supports the discovery, validation, and quantification of biomarkers. This integrated approach revolutionises our ability to study and understand complex biological systems across various therapeutic areas. Together, these tools empower researchers to delve deeper into biological systems and accelerate the discovery of new therapeutic targets.
Join our in-person or live-streamed seminar on Friday 21 March 2025 at 2 PM - 4 PM to find out all about our Olink proteomic services. The event will include Q & A panel discussion, refreshments and an opportunity to network.
To register for this event, please enter your details below.
